Zymeworks (ZYME) Net Income towards Common Stockholders (2021 - 2026)

Zymeworks' Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$44.2 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 95.1% year-over-year to -$44.2 million; the TTM figure through Mar 2026 stood at -$102.7 million (up 9.7% YoY), while the FY2025 annual figure was -$81.1 million, up 33.88% from the prior year.
• Net Income towards Common Stockholders came in at -$44.2 million for Q1 2026 at Zymeworks, down from -$41.2 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $309.4 million in Q4 2022 to a low of -$72.6 million in Q1 2022.
• A 5-year average of -$14.3 million and a median of -$29.8 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 890.33% in 2022 and tumbled 104.68% in 2023, its largest moves.
• Zymeworks' Net Income towards Common Stockholders stood at $309.4 million in 2022, then sank by 104.68% to -$14.5 million in 2023, then slumped by 62.31% to -$23.5 million in 2024, then sank by 75.31% to -$41.2 million in 2025, then retreated by 7.17% to -$44.2 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$44.2 million, -$41.2 million, and -$19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison